Government may 'rationalise' drug trade margins in a bid to reduce costs

The meeting was attended by representatives from the Indian Drug Manufacturers Association (IDMA) and Indian Pharmaceutical Alliance (IPA), The Organisation of Pharmaceutical Producers of India (OPPI), and All India Drug Action Network (AIDAN), among others. The All India Organisation of Chemists and Druggists (AIOCD) has suggested a 10% trade margin for wholesale dealers on PTR (price to retailer) and 20% for retailers on MRP.

from Healthcare/Biotech-Industry-Economic Times https://ift.tt/fWFTNpV
via IFTTT